David A. Siegel Ionis Pharmaceuticals Inc Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,287,111 shares of IONS stock, worth $51.6 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,287,111
Previous 1,040,111
23.75%
Holding current value
$51.6 Million
Previous $45.1 Million
36.05%
% of portfolio
0.14%
Previous 0.11%
Shares
28 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$555 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$506 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$413 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$331 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$263 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.69B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...